Transurethral ethanol ablation of prostate.
Transurethral ethanol ablation of the prostate (TEAP) has emerged among the treatment alternatives to transurethral resection of prostate as a promising minimally invasive therapy that can be performed on an outpatient basis with fewer complications. It was introduced approximately 5 years ago, and to date, 12-month results are encouraging. We herein review the procedure and outcomes of TEAP.
Buchholz
Noor N P
NN
Department of Urology, Barts and The Royal London Hospitals, London, United Kingdom.
Andrews
Henry O
HO
Plante
Mark K
MK
D000431:Ethanol / Q000008:administration & dosage*; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D011470:Prostatic Hyperplasia / Q000628:therapy*; D014521:Urethra
D000431:Ethanol